CN104387447A - 一种基于dc细胞的乙肝病毒t表位肽 - Google Patents
一种基于dc细胞的乙肝病毒t表位肽 Download PDFInfo
- Publication number
- CN104387447A CN104387447A CN201410586328.6A CN201410586328A CN104387447A CN 104387447 A CN104387447 A CN 104387447A CN 201410586328 A CN201410586328 A CN 201410586328A CN 104387447 A CN104387447 A CN 104387447A
- Authority
- CN
- China
- Prior art keywords
- cell
- virus
- hepatitis
- patient
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410586328.6A CN104387447A (zh) | 2011-03-25 | 2011-03-25 | 一种基于dc细胞的乙肝病毒t表位肽 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410586328.6A CN104387447A (zh) | 2011-03-25 | 2011-03-25 | 一种基于dc细胞的乙肝病毒t表位肽 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100738623A Division CN102190707A (zh) | 2011-03-25 | 2011-03-25 | 一种基于dc细胞的乙肝病毒t表位肽 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104387447A true CN104387447A (zh) | 2015-03-04 |
Family
ID=52605419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410586328.6A Pending CN104387447A (zh) | 2011-03-25 | 2011-03-25 | 一种基于dc细胞的乙肝病毒t表位肽 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104387447A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105622731A (zh) * | 2016-03-29 | 2016-06-01 | 江苏安泰生物技术有限公司 | 乙肝病毒核心抗原的ctl表位及其相关应用 |
CN114073764A (zh) * | 2020-08-19 | 2022-02-22 | 江苏安泰生物技术有限公司 | 一种高效抑制幽门螺杆菌的牙膏及其制备方法和其应用 |
-
2011
- 2011-03-25 CN CN201410586328.6A patent/CN104387447A/zh active Pending
Non-Patent Citations (1)
Title |
---|
罗进: "基于T细胞表位肽的树突细胞介导的靶向性细胞杀伤机制的研究", 《中国博士学位论文全文数据库医药卫生科技辑》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105622731A (zh) * | 2016-03-29 | 2016-06-01 | 江苏安泰生物技术有限公司 | 乙肝病毒核心抗原的ctl表位及其相关应用 |
CN114073764A (zh) * | 2020-08-19 | 2022-02-22 | 江苏安泰生物技术有限公司 | 一种高效抑制幽门螺杆菌的牙膏及其制备方法和其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69132365T2 (de) | Für den Nachweis von Antikörpern gegen HVC spezifische synthetische Peptide und Diagnose von HCV-Infektionen | |
Taboga et al. | A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants | |
Emini et al. | Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide | |
Botarelli et al. | T-lymphocyte response to hepatitis C virus in different clinical courses of infection | |
KR101732624B1 (ko) | 식물 유래의 돼지 열병 백신용 조성물 및 이의 제조방법 | |
US20060093617A1 (en) | Peptides for inducing a CTL and/or HTL response to hepatitis C virus | |
van Els et al. | A single naturally processed measles virus peptide fully dominates the HLA‐A* 0201‐associated peptide display and is mutated at its anchor position in persistent viral strains | |
TWI358301B (en) | Hcv vaccines | |
Christie et al. | Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus | |
CN101361969B (zh) | 一种治疗性乙肝疫苗及其制备方法和用途 | |
Roehrig et al. | T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus | |
CN113201051B (zh) | 一种乙肝病毒表面蛋白突变体及其在抗乙肝病毒中的应用 | |
WO2018217906A1 (en) | Methods and compositions for dengue virus serotype 4 epitopes | |
CN104387447A (zh) | 一种基于dc细胞的乙肝病毒t表位肽 | |
CARRENO et al. | Studies on antigenic variability of C strains of foot‐and‐mouth disease virus by means of synthetic peptides and monoclonal antibodies | |
CN102190707A (zh) | 一种基于dc细胞的乙肝病毒t表位肽 | |
Mahapatra et al. | Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains | |
US20060110401A1 (en) | Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof | |
CN106119195A (zh) | 一种用于诱导产生识别hpv的dc细胞的试剂盒以及诱导方法 | |
Frasca et al. | Antibody–Selected Mimics of Hepatitis C Virus Hypervariable Region 1 Activate Both Primary and Memory Th Lymphocytes | |
CN102675410A (zh) | 一种分支多肽的制备方法 | |
EP1652858A1 (en) | Peptides for inducing a CTL and/or HTL response to hepatitis C virus | |
US6787142B2 (en) | Mutant human hepatitis B viral strain and uses thereof | |
WO2006021048A1 (en) | Immunotherapy of virus infection | |
CN100412089C (zh) | 蜱传黄病毒的全长感染性cDNA克隆 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YAN PINGXI Free format text: FORMER OWNER: JIANGSU ANTAE BIOGENE TECHNOLOGY CO., LTD. Effective date: 20150604 Owner name: JIANGSU ANTAE BIOGENE TECHNOLOGY CO., LTD. Effective date: 20150604 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150604 Address after: Nanshan District Lake Road Shenzhen City, Guangdong province 518000 No. 45 Shanhaiguan Cui Lu, 1 5B Applicant after: Yan Pingxi Applicant after: JIANGSU ANTAE BIOGENE TECHNOLOGY CO., LTD. Address before: 225300 Jiangsu City, Taizhou medicine City Avenue, building G01, West building, building two Applicant before: JIANGSU ANTAE BIOGENE TECHNOLOGY CO., LTD. |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150304 |